Partnerships

Serious immunology moves faster with the right collaborators

We structure partnerships around a defined scientific question, an agreed endpoint and genuine data sharing. No vague memoranda of understanding.

Send a partnership enquiry

Models

Four ways we work together

Academic collaboration

Joint study design with a university group, shared authorship, and reciprocal access to assay capacity.

  • Co-designed protocol
  • Shared raw data
  • Joint publication

Clinical investigator network

Investigators contributing consented sample cohorts and clinical context to our profiling programmes.

  • IRB-approved sampling
  • De-identified datasets
  • Return of findings

Instrument & reagent partners

Method development partnerships with instrument and reagent vendors, including comparative validation work.

  • Validation study
  • Method publication
  • Named application note

Translational funding

Foundations, patient organizations and translational funds supporting a defined preclinical milestone.

  • Milestone-based
  • Quarterly reporting
  • Full data access

Process

From first call to kickoff

  1. 01

    Introductory call

    Thirty minutes to establish scientific fit and scope.

  2. 02

    Mutual NDA

    Standard bilateral agreement before any unpublished data moves.

  3. 03

    Scoping document

    Written objectives, endpoints, responsibilities and timeline.

  4. 04

    Agreement & kickoff

    Signed collaboration agreement, then work begins within four weeks.

Enquiry

Tell us what you're trying to answer

Send the scientific question first. Our partnerships lead reads every submission and replies within two working days, including when the answer is that we are not the right lab for it.

See currently open opportunities

We use these details only to respond to your enquiry. No confidential scientific data should be shared before a mutual NDA is in place.